Redirecting in 3 seconds…
Recent Press Releases
- Renalytix Selects EVERSANA to Expand Commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes
- Yaral Pharma Partners with EVERSANA to Support the Commercialization of its Expanded Generics Portfolio
- Shorla Oncology & EVERSANA Announce Commercial Launch of Recent FDA-Approved Nelarabine Injection for the Treatment of T-cell Leukemia Across the United States
- Two EVERSANA Leaders Named to Prestigious PM360 Elite 100 List
- Real-World Data Presented by Evoke Pharma and EVERSANA at Digestive Disease Week 2023 Shows Gimoti® Meaningfully Reduces Utilization of Healthcare Resources
Categories
Archives